Division of Clinical Epidemiology, University Hospital Geneva, Geneva, Switzerland.
HIV Med. 2009 Sep;10(8):470-6. doi: 10.1111/j.1468-1293.2009.00714.x. Epub 2009 May 6.
An article by the Swiss AIDS Commission states that patients with stably suppressed viraemia [i.e. several successive HIV-1 RNA plasma concentrations (viral loads, VL) below the limits of detection during 6 months or more of highly active antiretroviral therapy (HAART)] are unlikely to be infectious. Questions then arise: how reliable is the undetectability of the VL, given the history of measures? What factors determine reliability?
We assessed the probability (henceforth termed reliability) that the n+1 VL would exceed 50 or 1000 HIV-1 RNA copies/mL when the nth one had been <50 copies/mL in 6168 patients of the Swiss HIV Cohort Study who were continuing to take HAART between 2003 and 2007. General estimating equations were used to analyse potential factors of reliability.
With a cut-off at 50 copies/mL, reliability was 84.5% (n=1), increasing to 94.5% (n=5). Compliance, the current type of HAART and the first antiretroviral therapy (ART) received (HAART or not) were predictive factors of reliability. With a cut-off at 1000 copies/mL, reliability was 97.5% (n=1), increasing to 99.1% (n=4). Chart review revealed that patients had stopped their treatment, admitted to major problems with compliance or were taking non-HAART ART in 72.2% of these cases. Viral escape caused by resistance was found in 5.6%. No explanation was found in the charts of 22.2% of cases.
After several successive VLs at <50 copies/mL, reliability reaches approximately 94% with a cut-off of 50 copies/mL and approximately 99% with a cut-off at 1000 copies/mL. Compliance is the most important factor predicting reliability.
瑞士艾滋病委员会的一篇文章指出,病毒血症得到稳定抑制的患者(即经过 6 个月或更长时间的高效抗逆转录病毒治疗(HAART)后,连续多次 HIV-1 RNA 血浆浓度(病毒载量,VL)低于检测下限)不太可能具有传染性。那么问题就出现了:鉴于历史上采取的措施,VL 的不可检测性有多可靠?哪些因素决定了可靠性?
我们评估了在 2003 年至 2007 年间继续接受 HAART 的瑞士 HIV 队列研究的 6168 名患者中,当第 n 次 VL<50 拷贝/mL 时,第 n+1 次 VL 超过 50 或 1000 HIV-1 RNA 拷贝/mL 的概率(下文称为可靠性)。使用广义估计方程分析了可靠性的潜在因素。
当截止值为 50 拷贝/mL 时,可靠性为 84.5%(n=1),增加到 94.5%(n=5)。依从性、当前的 HAART 类型以及首次接受的抗逆转录病毒治疗(是否接受 HAART)是可靠性的预测因素。当截止值为 1000 拷贝/mL 时,可靠性为 97.5%(n=1),增加到 99.1%(n=4)。通过图表审查发现,在这些情况下,72.2%的患者停止了治疗,承认依从性存在严重问题或正在服用非 HAART 抗逆转录病毒药物。发现 5.6%的病例存在耐药引起的病毒逃逸。在 22.2%的病例中,图表中没有找到解释。
经过多次 VL<50 拷贝/mL 后,当截止值为 50 拷贝/mL 时,可靠性约为 94%,当截止值为 1000 拷贝/mL 时,可靠性约为 99%。依从性是预测可靠性的最重要因素。